
Pleae whatever you do... DO NOT TAKE THE NEW FDA APPROVED mFLUSIVA mRNA FLU SHOT Moderna’s first-ever mRNA flu vaccine was FDA-approved and rushed to market — loaded with red flags that echo COVID-era patterns. • 75.7% of mFLUSIVA recipients reported adverse reactions within 7 days... fever, extreme fatigue, severe headache and pain. • Severe systemic reactions were 5–6X higher with illness occurring in 1 out of every 20 participants. • The “placebo” was not saline — it was another flu vaccine Fluarix: No true inert placebo means the safety contrast is gone, and absolute risk versus nothing is unknown. • Safety follow-up was only about 6 months: Long-term effects, rare events, and multi-year outcomes remain completely untracked in the published data. • There were 102 deaths in the mRNA group: The FDA labeled them unrelated, yet no autopsies were performed — leaving complete uncertainty. • Same technology. Same pattern: Built on the identical mRNA platform as the COVID shots that produced high injuries, illnesses and deaths.
无论如何,请千万不要接种这款 2026年8月5日获得美国食品药品 监督管理总局(FDA)批准的 mRNA 流感疫苗——mFLUSIVA。
Moderna 公司推出的这款 mRNA 流感疫苗(首款此类疫苗)在获批 后被迅速推向市场,其背后存在诸多令人警惕的信号,与新冠疫情 期间的情况如出一辙。
• 75.7 % 的 mFLUSIVA 接种者在 7 天内出现了不良反应,包括发热、 极度疲劳、剧烈头痛及疼痛。
• 严重全身性反应的发生率高出 5 到 6 倍,平均每 20 名受试者中就 有 1 人出现此类严重反应。
• 试验中所谓的“安慰剂”并非生理盐水,而是另一种流感疫苗 Fluarix。由于缺乏真正惰性的安慰剂,安全性对比便无从谈起, 也无法评估其相对于“不接种任何疫苗”时的绝对风险。
• 安全性随访期仅约 6 个月;已发布的数据完全未涵盖长期影响、 罕见不良事件以及多年后的健康后果。
• 在 mRNA 疫苗组中,共有 102 人死亡。尽管 FDA 认定这些死亡与 疫苗无关,但由于未进行尸检,实际情况仍充满未知。
• 技术相同,模式如出一辙:该疫苗所采用的 mRNA 平台,与此前 曾导致大量伤害、疾病和死亡的新冠疫苗所用的平台完全一致。



https://journalofindependentmedicine.org/articles/v02n05a07/



我曾劝过我在单位的朋友你可别去打那些针! 结果,他特意跑去找医生,一口气打了一堆疫苗, 回来后,为此沾沾自喜!
他给我发了条信息,说: “ 瞧,我刚刚打了新冠、流感、麻疹、肺炎疫苗。 ”
https://x.com/Bruce98048832/status/2117853977773801612
|